Patent · US Expired

Pyrrolidine derivatives

US7189756B2 · kind B2 · utility

2Cited by

2References

59Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Johannes Aebi · Binningen, CH
Daniel Bur · Therwil, CH
Alexander Chucholowski · San Diego, US
Henrietta Dehmlow · Weil am Rhein, DE
Eric A. Kitas · Aesch, CH
Ulrike Obst · Weil am Rhein, DE
Hans Peter Wessel · Heitersheim, DE

Key dates

Filing date	Jun 30, 2004
Grant date	Mar 13, 2007
Priority date	—
Expiry date	Sep 24, 2024

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pyrrolidine derivatives useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in treating disease states associated with vasoconstriction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.